menu
    • menu

    Company profile for Athira Pharma

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Athira Pharma is a drug development company striving to improve human health by advancing new therapies for neurodegenerative diseases like Alzheimer’s and Parkinson’s. Our innovative approach is focused on turning brain degeneration into regeneration, achieved by re-establishing lost connections and restoring lost function.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Athira PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    CoMotion Labs @ Fluke Hall, 4000 Mason Rd, Suite 300, Box 352141, Seattle WA 9...
    Telephone
    Telephone
    (206) 221-8112)
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.athira.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Athira Pharma Rebrands To Leonabio
    Athira Pharma Rebrands To Leonabio

    09 Jan 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/marketing/athira-pharma-roars-new-year-rebrand-leonabio

    FIERCE PHARMA
    09 Jan 2026
    Share Share
    Athira License Lasofoxifene for $236M in Metastatic Breast Cancer
    Athira License Lasofoxifene for $236M in Metastatic Breast Cancer

    18 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/18/3207578/0/en/Athira-Pharma-Announces-Exclusive-License-to-Lasofoxifene-Phase-3-Development-Program-for-Metastatic-Breast-Cancer-Candidate-and-a-Financing-for-up-to-236-Million.html

    GLOBENEWSWIRE
    18 Dec 2025
    Share Share
    Athira Pharma Unveils Q3 2025 Financials & Business Update
    Athira Pharma Unveils Q3 2025 Financials & Business Update

    06 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/06/3183110/0/en/Athira-Pharma-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    06 Nov 2025
    Share Share
    Athira Pharma Initiates Reverse Stock Split
    Athira Pharma Initiates Reverse Stock Split

    11 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/11/3148572/0/en/Athira-Pharma-Announces-Reverse-Stock-Split.html

    GLOBENEWSWIRE
    11 Sep 2025
    Share Share
    Athira Pharma Unveils Ath-1105 Phase 1 Data at ALS Nexus 2025
    Athira Pharma Unveils Ath-1105 Phase 1 Data at ALS Nexus 2025

    14 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/14/3133303/0/en/Athira-Pharma-Presents-ATH-1105-Phase-1-Trial-Results-at-ALS-Nexus-2025.html

    GLOBENEWSWIRE
    14 Aug 2025
    Share Share
    Athira Pharma Reports Q2 2025 Financials, Updates on Business
    Athira Pharma Reports Q2 2025 Financials, Updates on Business

    07 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/07/3129673/0/en/Athira-Pharma-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    07 Aug 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search